This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: Roche Molecular Systems, Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Martin Moczko: Innovator in Nucleic Acid Testing
Introduction
Martin Moczko is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of molecular diagnostics, particularly in the area of nucleic acid testing. His innovative approach has led to the development of a patented method that enhances the accuracy of biomolecule detection.
Latest Patents
Martin Moczko holds a patent for a method related to the detection of target biomolecules in test samples. This invention involves adding an internal control biomolecule to various samples, including test samples, negative control samples, and positive control samples. The method allows for the determination of a signal in each sample, thereby verifying the presence of the target biomolecule. This patent is crucial for improving the reliability of nucleic acid testing.
Career Highlights
Throughout his career, Martin Moczko has worked with prominent companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has equipped him with the expertise necessary to innovate in the field of molecular diagnostics.
Collaborations
Martin has collaborated with esteemed colleagues such as Thomas Emrich and Gerd Haberhausen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Martin Moczko is a distinguished inventor whose work in nucleic acid testing has the potential to significantly impact the field of molecular diagnostics. His innovative methods and collaborations highlight his commitment to advancing scientific research and improving diagnostic accuracy.